CHEMTHANE 1150 PART A

Hazard statements (CLP)

H303, H315, H317, H319, H334, H336, H351

Code

Statements

H303

May be harmful if swallowed

OSHA HCS Classification

Health, Acute toxicity, 5 Oral Health, Skin corrosion/irritation, 2 Health, Serious Eye Damage/Eye Irritation, 2 A Health, Respiratory or skin sensitization, 1 Respiratory Health, Respiratory or skin sensitization, 1 Skin Health, Carcinogenicity, 2 Health, Specific target organ toxicity - Single exposure, 3

Signal word

DANGER

Hazard statements

H303 - May be harmful if swallowed H315 - Causes skin irritation H319 - Causes serious eye irritation H334 - May cause allergy or asthma symptoms of breathing difficulties if inhaled H317 - May cause an allergic skin reaction H351 - Suspected of causing cancer H336 - May cause drowsiness or dizziness

Precautionary statements

P260 - Do not breathe dust/fume/gas/mist/vapors/spray. P280 - Wear protective gloves/protective clothing/eye protection/face protection. P284 - Wear respiratory protection. P305+351+338 - IF IN EYES: Rinse continuously with water for several minutes. Remove contact lenses if present and easy to do. Continue rinsing. P310 - Immediately call a POISON CENTER or doctor/physician.

Principle Routes of Exposure

Eyes; Ingestion; Inhalation; Skin; Target Organs: Respiratory system; Skin; Eyes; Inhalation: At room temperature, MDI vapors are minimal due to low vapor pressure. However, heating, spraying, foaming, or otherwise mechanically dispersing (drumming, venting or pumping) operations may generate vapor or aerosol concentrations sufficient to cause irritation or other adverse effects. Excessive exposure may cause irritation of the eyes, upper respiratory tract and lungs. Severe overexposure may lead to pulmonary edema. May cause respiratory sensitization with asthma-like symptoms in susceptible individuals. MDI concentrations below the exposure guidelines may cause allergic respiratory reactions in individuals already sensitized. Symptoms may include coughing, dryness of throat, headache, nausea, difficult breathing and a feeling of tightness in the chest. Effects may be delayed. Impaired lung function (decreased ventilator capacity) has been associated with overexposure to isocyanates Chronic: As a result of previous repeated overexposures or a single large dose, certain individuals develop isocyanate sensitization (chemical asthma) or tissue injury in the upper respiratory tract. Animal tests indicate skin contact alone may also lead to allergic respiratory reaction. These effects may be permanent. Any person developing asthmatic reaction or other sensitization should be removed from further exposure Skin Contact: No irritation is likely to develop following short contact periods with skin. Prolonged or repeated exposure can cause skin irritation, reddening, dermatitis, and in some individuals, sensitization. Skin contact may result in allergic skin reactions or respiratory sensitization, but is not expected to result in absorption of amounts sufficient to cause other adverse effects. May stain skin. Eye Contact: As a liquid or dust, may cause irritation, inflammation, and/or damage to sensitive eye tissue. Symptoms include watering or discomfort of the eyes. Corneal injury is unlikely.